Showing results (121-130 of 245) with videos related to

Sort By:
Pageof 25
Journal of the American College of Cardiology|October 2, 2024
Influence of Subclinical Atherosclerosis Burden and Progression on MortalityValentin Fuster, Ana García-Álvarez, Ana Devesa, et al.
Diabetes Care|May 6, 2020
Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER TrialJohn B Buse, Stephen C Bain, Johannes F E Mann, et al.
Circulation|June 15, 2007
Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programEileen O'Meara, Tim Clayton, Margaret B McEntegart, et al.
Emergencias : Revista De La Sociedad Espanola De Medicina De Emergencias|January 19, 2019
Patients with acute heart failure discharged from the emergency department and classified as low risk by the MEESSI score (multiple risk estimate based on the Spanish emergency department scale): prevalence of adverse events and predictabilityÒscar Miró, Víctor Gil, Xavier Rosselló, et al.
Clinical Cardiology|November 1, 2022
Multimorbidity, functional impairment, and mortality in older patients stable after prior acute myocardial infarction: Insights from the TIGRIS registryAkshay Bagai, Faeez M Ali, John Gregson, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 5, 2019
Incidence, predictors, and outcomes of DAPT disruption due to non-compliance vs. bleeding after PCI: insights from the PARIS RegistryKamilia Moalem, Usman Baber, Jaya Chandrasekhar, et al.
The Lancet Regional Health. Europe|July 18, 2025
Cost-effectiveness of the CV-polypill strategy versus standard care for secondary cardiovascular prevention in Spain: an analysis based on the SECURE trialThomas Gaziano, José María Castellano, Amy Dymond, et al.
Lancet (London, England)|May 28, 2018
Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trialDavid E Kandzari, Michael Böhm, Felix Mahfoud, et al.
Open Heart|February 10, 2021
Health-related quality of life 1-3 years post-myocardial infarction: its impact on prognosisStuart Pocock, David B Brieger, Ruth Owen, et al.
Circulation|October 23, 2023
Safety and Efficacy of Ticagrelor Monotherapy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: An Individual Patient Data Meta-Analysis of TWILIGHT and TICO Randomized TrialsUsman Baber, Yangsoo Jang, Angelo Oliva, et al.
Pageof 25